Ciprofloxacin 0 recalled over temperature-control failures
- Recall date
- August 13, 2025
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Sandoz Inc recalls Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic Suspension Rx Only, For Use in Ears Only, Manufactured By: Novartis Manu…
- Recall number
- D-0626-2025
- FDA classification
- Class II
- Brand / firm
- Sandoz Inc
- Sold / distributed
- Product was distributed to one consignee in CA.
Why it was recalled
Temperature Abuse
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic Suspension Rx Only, For Use in Ears Only, Manufactured By: Novartis Manufacturing NV, Belgium, Distributed by: Sandoz, Inc., Princeton, NJ, NDC# 0781-6186-67, Carton NDC# 0781-6186-67
Get recall alerts
Free email alert whenever Sandoz Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Sandoz Inc